MALDI imaging MS of phospholipids in the mouse lung

Journal of Lipid Research

Volumn 52, Issue 8, 2011, Pages 1551-1560

  Berry, Karin A Zemski ^a   Li, Bilan ^b   Reynolds, Susan D ^b   Barkley, Robert M ^a   Gijón, Miguel A ^a   Hankin, Joseph A ^a   Henson, Peter M ^b   Murphy, Robert C ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF MEDICINE   (United States)

Author keywords

Arachidonic acid; Cryoembedding agent; Lipid localization; Lipid mediators; Mass spectrometry; Pulmonary tissue

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; LUNG SURFACTANT; PHOSPHOLIPID DERIVATIVE; POLYUNSATURATED FATTY ACID; SPHINGOMYELIN;

ANALYTIC METHOD; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; IMMUNOHISTOCHEMISTRY; LIPID ANALYSIS; LUNG ALVEOLUS EPITHELIUM; LUNG BLOOD VESSEL; LUNG PARENCHYMA; MATRIX ASSISTED LASER DESORPTION IONIZATION; MOLECULAR IMAGING; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

ANIMALS; ARACHIDONIC ACID; BLOOD VESSELS; DOCOSAHEXAENOIC ACIDS; FLUORESCENT ANTIBODY TECHNIQUE; LIPID METABOLISM; LUNG; MICE; MICE, INBRED C57BL; PHOSPHOLIPIDS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SPHINGOMYELINS;

EID: 79960691660     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M015750     Document Type: Article

References (37)

1. Stables, M. J., and D. W. Gilroy. 2011. Old and new generation lipid mediators in acute inflammation and resolution. Prog. Lipid Res. 50: 35-51.
2. Numata, M., H. W. Chu, A. Dakhama, and D. R. Voelker. 2010. Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced inflammation and infection. Proc. Natl. Acad. Sci. USA. 107: 320-325.
3. Griese, M. 1999. Pulmonary surfactant in health and human lung diseases: state of the art. Eur. Respir. J. 13: 1455-1476.
4. Samuelsson, B., S. E. Dahlen, J. A. Lindgren, C. A. Rouzer, and C. N. Serhan. 1987. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science. 237: 1171-1176.
5. Lewis, R. A., K. F. Austen, and R. J. Soberman. 1990. Leukotrienes and other products of the 5-lipoxygenase pathway: biochemistry and relation to pathobiology in human diseases. N. Engl. J. Med. 323: 645-655.
6. Riccioni, G., T. Bucciarelli, B. Mancini, C. Di Ilio, and N. D'Orazio. 2007. Antileukotriene drugs: clinical application, effectiveness and safety. Curr. Med. Chem. 14: 1966-1977.
7. Serhan, C. N., and N. Chiang. 2008. Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br. J. Pharmacol. 153 (Suppl.): 200-215.
8. Schürch, S., M. Lee, and P. Gehr. 1992. Pulmonary surfactant: surface properties and function of alveolar and airway surfactant. Pure Appl. Chem. 64: 1745-1750.
9. Kuronuma, K., H. Mitsuzawa, K. Takeda, C. Nishitani, E. D. Chan, Y. Kuroki, M. Nakamura, and D. R. Voelker. 2009. Anionic pulmonary surfactant phospholipids inhibit inflammatory responses from alveolar macrophages and U937 cells by binding the lipopolysaccharide- interacting proteins CD14 and MD-2. J. Biol. Chem. 284: 25488-25500.
10. Greenspan, P., E. P. Mayer, and S. D. Fowler. 1985. Nile red: a selective fluorescent stain for intracellular lipid droplets. J. Cell Biol. 100: 965-973.
11. van Goor, H., P. O. Gerrits, and J. Grond. 1986. The application of lipid-soluble stains in plastic-embedded sections. Histochemistry. 85: 251-253.
12. Rudolf, M., and C. A. Curcio. 2009. Esterified cholesterol is highly localized to Bruch's membrane, as revealed by lipid histochemistry in wholemounts of human choroid. J. Histochem. Cytochem. 57: 731-739.
13. Rossetto, V., L. Spiezia, F. Franz, L. Salmaso, L. V. Pozza, S. Gavasso, and P. Simoni. 2009. The role of antiphospholipid antibodies toward the protein C/protein S system in venous thromboembolic disease. Am. J. Hematol. 84: 594-596.
14. Ikeda, K., and R. Taguchi. 2010. Highly sensitive localization analysis of gangliosides and sulfatides including structural isomers in mouse cerebellum sections by combination of laser microdissection and hydrophilic interaction liquid chromatography/electrospray ionization mass spectrometry with theoretically expanded multiple reaction monitoring. Rapid Commun. Mass Spectrom. 24: 2957-2965.
15. Cornett, D. S., M. L. Reyzer, P. Chaurand, and R. M. Caprioli. 2007. MALDI imaging mass spectrometry: molecular snapshots of biochemical systems. Nat. Methods. 4: 828-833.
16. Fuchs, B., R. Süss, and J. Schiller. 2010. An update of MALDI-TOF mass spectrometry in lipid research. Prog. Lipid Res. 49: 450-475.
17. Hankin, J. A., and R. C. Murphy. 2010. Relationship between MALDI-MSI intensity and measured quantity of selected phospholipids in rat brain sections. Anal. Chem. 82: 8476-8484.
18. Myung, J. K., G. Choe, D. H. Chung, J. W. Seo, S. Jheon, C. Lee, and J. Chung. 2008. A simple inflation method for frozen section diagnosis of minute precancerous lesions of the lung. Lung Cancer. 59: 198-202. (Pubitemid 351173411)
19. Hankin, J. A., R. M. Barkley, and R. C. Murphy. 2007. Sublimation as a method of matrix application for mass spectrometric imaging. J. Am. Soc. Mass Spectrom. 18: 1646-1652.
20. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917.
21. Berry, K. A., and R. C. Murphy. 2005. Analysis of cell membrane aminophospholipids as isotope-tagged derivatives. J. Lipid Res. 46: 1038-1046.
22. Schwartz, S. A., M. L. Reyzer, and R. M. Caprioli. 2003. Direct tissue analysis using matrix-assisted laser desorption/ionization mass spectrometry: practical aspects of sample preparation. J. Mass Spectrom. 38: 699-708.
23. Cocco, C., G. V. Melis, and G. L. Ferri. 2003. Embedding media for cryomicrotomy: an applicative reappraisal. Appl. Immunohistochem. Mol. Morphol. 11: 274-280.
24. Pulfer, M., and R. C. Murphy. 2003. Electrospray mass spectrometry of phospholipids. Mass Spectrom. Rev. 22: 332-364.
25. Murphy, R. C. 2002. Tables of molecular and product ions. In Mass Spectrometry of Phospholipids. Illuminati Press, Denver, CO. 26-53.
26. Murphy, R. C., J. A. Hankin, and R. M. Barkley. 2009. Imaging of lipid species by MALDI mass spectrometry. J. Lipid Res. 50 (Suppl.): 317-322.
27. McDonnell, L. A., and R. M. Heeren. 2007. Imaging mass spectrometry. Mass Spectrom. Rev. 26: 606-643.
28. Veldhuizen, R., K. Nag, S. Orgeig, and F. Possmayer. 1998. The role of lipids in pulmonary surfactant. Biochim. Biophys. Acta. 1408: 90-108.
29. Bernhard, W., J. Y. Wang, T. Tschernig, B. Tümmler, H. J. Hedrich, and H. von der Hardt. 1997. Lung surfactant in a cystic fibrosis animal model: increased alveolar phospholipid pool size without altered composition and surface tension function in cftrm1HG/m1HGU mice. Thorax. 52: 723-730. (Pubitemid 27404988)
30. Lang, C. J., A. D. Postle, S. Orgeig, F. Possmayer, W. Bernhard, A. K. Panda, K. D. Jürgens, W. K. Milsom, K. Nag, and C. B. Daniels. 2005. Dipalmitoylphosphatidylcholine is not the major surfactant phospholipid species in all mammals. Am. J. Physiol. Regul. Integr. Comp. Physiol. 289: R1426-R1439.
31. Postle, A. D., E. L. Heeley, and D. C. Wilton. 2001. A comparison of the molecular species compositions of mammalian lung surfactant phospholipids. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 129: 65-73.
32. Holtzman, M. J., D. Grunberger, and J. A. Hunter. 1986. Phospholipid fatty acid composition of pulmonary airway epithelial cells: potential substrates for oxygenation. Biochim. Biophys. Acta. 877: 459-464.
33. Postle, A. D., L. W. Gonzales, W. Bernhard, C. T. Clark, M. H. Godinez, R. I. Godinez, and P. L. Ballard. 2006. Lipidomics of cellular and secreted phospholipids from differentiated human fetal type II alveolar epithelial cells. J. Lipid Res. 47: 1322-1331.
34. Lands, W. E. M. 1960. Metabolism of glycerolipids. II. The enzymatic acylation of lysolecithin. J. Biol. Chem. 235: 2233-2237.
35. Gijón, M. A., W. R. Riekhof, S. Zarini, R. C. Murphy, and D. R. Voelker. 2008. Lysophospholipid acyltransferases and arachidonate recycling in human neutrophils. J. Biol. Chem. 283: 30235-30245.
36. Hallstrand, T. S., and W. R. Henderson, Jr. 2010. An update on the role of leukotrienes in asthma. Curr. Opin. Allergy Clin. Immunol. 10: 60-66.
37. Kilfeather, S. 2002. 5-Lipoxygenase inhibitors for the treatment of COPD. Chest. 121 (Suppl.): 197-200.